Methods: Continentalic Acid from Aralia continentalis exhibited potent activity against standard methicillin-sensitive Staphylococcu aureus (MSSA) as well as clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA).
Results: It was determined that the continentalic acid had minimum inhibitory concentrations (MICs) of approximately 8-16 µg/ml against S. aureus, including the MSSA and MRSA standard strains.
Conclusions: The results obtained in this study suggest that continentalic acid might have the potential to be adjunct in the treatment of antibiotic-resistant bacteria.